Comparative Study of TPGS and Soluplus Polymeric Micelles Embedded in Poloxamer 407 In Situ Gels for Intranasal Administration
This study aims to highlight the importance of choosing the appropriate co-polymer or co-polymer mixed combinations in order to design value-added nasal dosage forms. Local therapy of upper respiratory tract-related infections, such as nasal rhinosinusitis is of paramount importance, thus advanced l...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | GELS (BASEL)
10 No. 8 |
| Tárgyszavak: | |
| doi: | 10.3390/gels10080521 |
| mtmt: | 35165412 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/34437 |
| LEADER | 02189nab a2200265 i 4500 | ||
|---|---|---|---|
| 001 | publ34437 | ||
| 005 | 20240826120827.0 | ||
| 008 | 240826s2024 hu o 000 eng d | ||
| 022 | |a 2310-2861 | ||
| 024 | 7 | |a 10.3390/gels10080521 |2 doi | |
| 024 | 7 | |a 35165412 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sipos Bence | |
| 245 | 1 | 0 | |a Comparative Study of TPGS and Soluplus Polymeric Micelles Embedded in Poloxamer 407 In Situ Gels for Intranasal Administration |h [elektronikus dokumentum] / |c Sipos Bence |
| 260 | |c 2024 | ||
| 300 | |a 14 | ||
| 490 | 0 | |a GELS (BASEL) |v 10 No. 8 | |
| 520 | 3 | |a This study aims to highlight the importance of choosing the appropriate co-polymer or co-polymer mixed combinations in order to design value-added nasal dosage forms. Local therapy of upper respiratory tract-related infections, such as nasal rhinosinusitis is of paramount importance, thus advanced local therapeutic options are required. Dexamethasone was encapsulated into three different polymeric micelle formulations: Soluplus or TPGS-only and their mixed combinations. Dynamic light scattering measurements proved that the particles have a micelle size less than 100 nm in monodisperse distribution, with high encapsulation efficiency above 80% and an at least 7-fold water solubility increase. Tobramycin, as an antimicrobial agent, was co-formulated into the in situ gelling systems which were optimized based on gelation time and gelation temperature. The sol–gel transition takes place between 32–35 °C, which is optimally below the temperature of the nasal cavity in a quick manner below 5 min, a suitable strategic criterion against the mucociliary clearance. In vitro drug release and permeability studies confirmed a rapid kinetics in the case of the encapsulated dexamethasone accompanied with a sustained release of tobramycin, as the hydrophilic drug. | |
| 650 | 4 | |a Általános orvostudomány | |
| 700 | 0 | 1 | |a Földes Frézia |e aut |
| 700 | 0 | 2 | |a Budai-Szűcs Mária |e aut |
| 700 | 0 | 2 | |a Katona Gábor |e aut |
| 700 | 0 | 2 | |a Pannonhalminé Csóka Ildikó |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/34437/1/gels-10-00521.pdf |z Dokumentum-elérés |